| 000 | 02578nam a22004937a 4500 | ||
|---|---|---|---|
| 008 | 200103s20192019 xxu||||| |||| 00| 0 eng d | ||
| 022 | _a1551-7489 | ||
| 024 | _a10.5055/jom.2019.0524 [doi] | ||
| 024 | _ajom.2019.0524 [pii] | ||
| 040 | _aOvid MEDLINE(R) | ||
| 099 | _a31849026 | ||
| 245 | _aCurrent practices in naloxone prescribing upon hospital discharge. | ||
| 251 | _aJournal of Opioid Management. 15(5):357-361, 2019 Sep/Oct. | ||
| 252 | _aJ Opioid Manag. 15(5):357-361, 2019 Sep/Oct. | ||
| 253 | _aJournal of opioid management | ||
| 260 | _c2019 | ||
| 260 | _fFY2020 | ||
| 265 | _sppublish | ||
| 266 | _d2020-01-03 | ||
| 520 | _aCONCLUSIONS: Providers agree with the Centers for Disease Control and Prevention recommendations to prescribe naloxone to high-risk patients. Certain barriers affect the rate of naloxone prescribing at discharge, including lack of time, patient education, provider training, and concern for increasing riskier behaviors. | ||
| 520 | _aDESIGN: Electronic cross-sectional survey. | ||
| 520 | _aMAIN OUTCOME MEASURES: Respondents completed survey items including current naloxone prescribing practices, barriers to naloxone prescribing, and methods to improve naloxone prescribing. | ||
| 520 | _aOBJECTIVE: To evaluate current practices in naloxone prescribing upon hospital discharge. | ||
| 520 | _aPARTICIPANTS: Inpatient physicians and advanced practice providers. | ||
| 520 | _aRESULTS: The survey response rate was 51.6 percent. Greater than 90 percent of respondents agreed that naloxone should be prescribed for patients with an active opioid use disorder, history of overdose, and use of greater than 50 morphine milligram equivalents per day. Lack of patient education on proper use of naloxone was the most identified barrier to prescribing. | ||
| 520 | _aSETTING: Academic medical center. | ||
| 546 | _aEnglish | ||
| 650 | _a*Drug Overdose | ||
| 650 | _a*Naloxone | ||
| 650 | _a*Patient Discharge | ||
| 650 | _a*Practice Patterns, Physicians' | ||
| 650 | _aAnalgesics, Opioid/tu [Therapeutic Use] | ||
| 650 | _aCross-Sectional Studies | ||
| 650 | _aDrug Overdose/pc [Prevention & Control] | ||
| 650 | _aHumans | ||
| 650 | _aNarcotic Antagonists | ||
| 651 | _aMedStar Washington Hospital Center | ||
| 656 | _aMedicine/Internal Medicine | ||
| 657 | _aJournal Article | ||
| 700 | _aPunzal, Michelle | ||
| 790 | _aHall AM, Li X, Oyler DR, Punzal M, Santos P | ||
| 856 |
_uhttps://dx.doi.org/10.5055/jom.2019.0524 _zhttps://dx.doi.org/10.5055/jom.2019.0524 |
||
| 942 |
_cART _dArticle |
||
| 999 |
_c4866 _d4866 |
||